NBIX   $120.44  0.49% Market Closed After Close 120.46 0.02%

Neurocrine Biosciences Inc
Total Cash 1.04B
totalCashPerShare 10.289
EBITDA 569.40M
Total Debt 291.60M
quickRatio 3.782
currentRatio 4.19
Total Revenue 2.12B
debtToEquity 11.621
Revenue/Share 21.377
ROA 0.11505
ROE 0.15552
grossProfits
freeCashflow 496.06M
operatingCashflow 530.40M
earningsGrowth -0.34
revenueGrowth 0.304
grossMargins 0.68549
ebitdaMargins 0.26865
operatingMargins 0.25059
profitMargins 0.16003999
enterpriseValue 11.60B
forwardPE 17.514326
floatShares 99.77M
sharesOutstanding 100.98M
sharesShort 2.14M
sharesShortPriorMonth 2.67M
dateShortInterest
sharesPercentSharesOut 0.02%
heldPercentInsiders 0.01%
heldPercentInstitutions 0.96%
Short Ratio help_outline 2.05%
shortPercentOfFloat 0.02%
impliedSharesOutstanding
bookValue 24.868
Price To Book help_outline 4.92
earningsQuarterlyGrowth -0.32
netIncomeToCommon 339.20M
trailingEps 3.33%
forwardEps 6.98%
enterpriseToEbitda 20.37
lastDividendValue
lastDividendDate
currentQuarterEstimate 1.55 3Q 2024
institutionsCount 895
lastUpdated Sept. 16, 2024, 11:22 a.m.